Vivos Therapeutics (VVOS) Cash from Investing Activities Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -160.99% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 16.37% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | -14.71% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | -25.15% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 92.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92.96% |
| Mar 31, 2026 | 85.25% |
| Dec 31, 2025 | -858.18% |
| Sep 30, 2025 | 143.23% |
| Jun 30, 2025 | -9,743.33% |
| Mar 31, 2025 | 19.21% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -24.68% |
| Jun 30, 2024 | 75.51% |
| Mar 31, 2024 | 47.75% |
| Dec 31, 2023 | 17.50% |
| Sep 30, 2023 | -54.00% |
| Jun 30, 2023 | 51.39% |
| Mar 31, 2023 | -140.83% |
| Dec 31, 2022 | 47.64% |
| Sep 30, 2022 | 76.85% |
| Jun 30, 2022 | 67.10% |
| Mar 31, 2022 | 54.20% |
| Dec 31, 2021 | -302.15% |
| Sep 30, 2021 | -3,498.80% |